New Scientist -- A mimic of the potent proteins used by white blood cells to punch holes in bacteria is to begin clinical trials in Canada. It could be a valuable new weapon against the growing threat of antibiotic-resistant “superbugs”.
New Scientist -- A mimic of the potent proteins used by white blood cells to punch holes in bacteria is to begin clinical trials in Canada. It could be a valuable new weapon against the growing threat of antibiotic-resistant “superbugs”.
